SULPIRIDE Side Effects

6756898-5 | Electrocardiogram Qt Prolonged, Ventricular Extrasystoles
on May 24, 2010 Female patient from JAPAN , 25 years of age, weighting 81.57 lb, was diagnosed with depression (What is depression?) and was treated with Sulpiride (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged, ventricular extrasystoles. Sulpiride dosage: Unk Mg, Unk. During the same period patient was treated with FLUVOXAMINE MALEATE (Unk Mg, Unk) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), PEROSPIRONE (Unk Mg, Unk) (View Perospirone Review and Perospirone Label ), FLUNITRAZEPAM (Unk Mg, Unk) (View Flunitrazepam Review and Flunitrazepam Label ), HALCION (0.125 Mg, Unk) (View Halcion Review and Halcion Label ).

6589420-7 | Disseminated Intravascular Coagulation, Multi-organ Failure, Neuroleptic Malignant Syndrome
Patient was taking Sulpiride (View Usage). Patient had the following side effects: disseminated intravascular coagulation, multi-organ failure, neuroleptic malignant syndrome on Dec 01, 2009 from JAPAN Additional patient health information: Male patient , 82 years of age, was diagnosed with depression (What is depression?), cardiac failure chronic, pneumonia (What is pneumonia?), atrial fibrillation (What is atrial fibrillation?), cardiac failure congestive and. Sulpiride dosage: . During the same period patient was treated with CERCINE (View Cercine Review and Cercine Label ), ARTIST (View Artist Review and Artist Label ), KLARICID (View Klaricid Review and Klaricid Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

5669348-7 | Abnormal Behaviour, Agitation, Anxiety, Anxiety Disorder, Eosinophil Count Increased, Eosinophilia, Insomnia
Adverse event was reported on Mar 03, 2008 by a Female patient taking Sulpiride (View Usage) (Dosage: 150 Mg/d) was diagnosed with temporal lobe epilepsy and. Location: JAPAN , 39 years of age, After Sulpiride was administered, patient had the following side effects: abnormal behaviour, agitation, anxiety (What is anxiety?), anxiety disorder, eosinophil count increased, eosinophilia, insomnia. During the same period patient was treated with OLANZAPINE (10 Mg/d) (View Olanzapine Review and Olanzapine Label ), TEGRETOL (Unk, Unk) (View Tegretol Review and Tegretol Label ), ZONISAMIDE (300 Mg/d) (View Zonisamide Review and Zonisamide Label ). Patient was hospitalized.

4916491-3 | Initial Insomnia, Neutrophil Count Decreased
on Oct 31, 2005 Female patient from JAPAN , weighting 125.7 lb, was diagnosed with depression (What is depression?), insomnia, prophylaxis, constipation (What is constipation?) and was treated with Sulpiride (View Usage). Patient experienced the following unwanted or unexpected effects: initial insomnia, neutrophil count decreased. Sulpiride dosage: Daily Dose: 150 Milligram(s). During the same period patient was treated with DEPROMEL 25 (Daily Dose: 50 Milligram(s)) (View Depromel 25 Review and Depromel 25 Label ), LENDORMIN (Daily Dose: .25 Milligram(s)) (View Lendormin Review and Lendormin Label ), INTRON A (Daily Dose: 300 Miu(1,000,000s) Twice A Week) (View Intron A Review and Intron A Label ), MAGNESIUM OXIDE (Daily Dose: 1.5 Gram(s)) (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.


4892499-1 | Initial Insomnia, Neutropenia
on Oct 31, 2005 Female patient from JAPAN , weighting 125.7 lb, was diagnosed with depression (What is depression?), insomnia, prophylaxis, constipation (What is constipation?) and was treated with Sulpiride (View Usage). Patient had the following side effects: initial insomnia, neutropenia. Sulpiride dosage: Daily Dose: 150 Milligram(s). During the same period patient was treated with DEPROMEL 25 (Daily Dose: 50 Milligram(s)) (View Depromel 25 Review and Depromel 25 Label ), LENDORMIN (Daily Dose: .25 Milligram(s)) (View Lendormin Review and Lendormin Label ), INTRON A (Daily Dose: 300 Miu(1,000,000s) Twice A Week) (View Intron A Review and Intron A Label ), MAGNESIUM OXIDE (Daily Dose: 1.5 Gram(s)) (View Magnesium Oxide Review and Magnesium Oxide Label ). Patient was hospitalized.

4832357-1 | Neutropenia
Patient was taking Sulpiride (View Usage). After Sulpiride was administered, patient had the following side effects: neutropenia on Oct 31, 2005 from JAPAN Additional patient health information: Female patient , 54 years of age, was diagnosed with depression (What is depression?), sleep disorder (What is sleep disorder?) and. Sulpiride dosage: Daily Dose: 150 Milligram(s). During the same period patient was treated with LUVOX (Daily Dose: 50 Milligram(s)) (View Luvox Review and Luvox Label ), BROTIZOLAM (Daily Dose: .25 Milligram(s)) (View Brotizolam Review and Brotizolam Label ). Patient was hospitalized.

4825667-5 | Hypomania, Neutropenia
Adverse event was reported on Oct 31, 2005 by a Female patient taking Sulpiride (View Usage) (Dosage: Daily Dose: 150 Milligram(s)) was diagnosed with depression (What is depression?), sleep disorder (What is sleep disorder?) and. Location: JAPAN , 54 years of age, Patient experienced the following unwanted or unexpected effects: hypomania, neutropenia. During the same period patient was treated with LUVOX (Daily Dose: 100 Milligram(s)) (View Luvox Review and Luvox Label ), BROTIZOLAM (Daily Dose: .25 Milligram(s)) (View Brotizolam Review and Brotizolam Label ).

4819035-X | Head Titubation, Hyperhidrosis, Muscle Spasms, Pallor
on Oct 31, 2005 Male patient from UNITED KINGDOM , 14 years of age, was diagnosed with tourette's disorder, obsessive-compulsive disorder (What is obsessive-compulsive disorder?) and was treated with Sulpiride (View Usage). Patient had the following side effects: head titubation, hyperhidrosis, muscle spasms, pallor. Sulpiride dosage: Daily Dose: 800 Milligram(s). During the same period patient was treated with FLUVOXAMINE MALEATE (Daily Dose: 100 Milligram(s)) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ).

4776063-0 | Constipation, Delirium, Difficulty In Walking, Dizziness, Hyperhidrosis, Muscle Rigidity, Neuroleptic Malignant Syndrome, Tachycardia
on Aug 31, 2005 Female patient from JAPAN , 73 years of age, was diagnosed with depression (What is depression?), major depression and was treated with Sulpiride (View Usage). After Sulpiride was administered, patient had the following side effects: constipation (What is constipation?), delirium, difficulty in walking, dizziness (What is dizziness?), hyperhidrosis, muscle rigidity, neuroleptic malignant syndrome, tachycardia. Sulpiride dosage: . During the same period patient was treated with LUDIOMIL (View Ludiomil Review and Ludiomil Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), MIANSERIN (View Mianserin Review and Mianserin Label ), BROMPERIDOL (View Bromperidol Review and Bromperidol Label ), ANAFRANIL (150 Mg/day) (View Anafranil Review and Anafranil Label ).

4771086-X | Azotaemia, Disseminated Intravascular Coagulation, Myoglobinuria, Neuroleptic Malignant Syndrome
Patient was taking Sulpiride (View Usage). Patient experienced the following unwanted or unexpected effects: azotaemia, disseminated intravascular coagulation, myoglobinuria, neuroleptic malignant syndrome on Mar 26, 1992 from Additional patient health information: Male patient , 46 years of age, . Sulpiride dosage: . During the same period patient was treated with MAPROTILINE (View Maprotiline Review and Maprotiline Label ). Patient was hospitalized.

4767208-7 | Akinesia, Azotaemia, Disseminated Intravascular Coagulation, Hyperthermia, Muscle Rigidity, Muscular Weakness, Myoglobinuria, Neuroleptic Malignant Syndrome, Oliguria
Adverse event was reported on Sep 30, 1992 by a Male patient taking Sulpiride (View Usage) (Dosage: 150 Mg, Qd) . Location: , 46 years of age, Patient had the following side effects: akinesia, azotaemia, disseminated intravascular coagulation, hyperthermia, muscle rigidity, muscular weakness, myoglobinuria, neuroleptic malignant syndrome, oliguria. During the same period patient was treated with LUDIOMIL (View Ludiomil Review and Ludiomil Label ). Patient was hospitalized.

4762527-2 | Constipation, Delirium, Difficulty In Walking, Dizziness, Hyperhidrosis, Muscle Rigidity, Neuroleptic Malignant Syndrome, Tachycardia
on Aug 31, 2005 Female patient from JAPAN , 76 years of age, was diagnosed with depression (What is depression?) and was treated with Sulpiride (View Usage). After Sulpiride was administered, patient had the following side effects: constipation (What is constipation?), delirium, difficulty in walking, dizziness (What is dizziness?), hyperhidrosis, muscle rigidity, neuroleptic malignant syndrome, tachycardia. Sulpiride dosage: . During the same period patient was treated with MAPROTILINE HYDROCHLORIDE (View Maprotiline Hydrochloride Review and Maprotiline Hydrochloride Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), MIANSERIN (View Mianserin Review and Mianserin Label ), BROMPERIDOL (View Bromperidol Review and Bromperidol Label ), CLOMIPRAMINE HCL (View Clomipramine Hcl Review and Clomipramine Hcl Label ).

4678244-3 | Haemorrhagic Diathesis, Oedema Peripheral, Paraesthesia Oral
on May 19, 2005 Male patient from , 36 years of age, was diagnosed with ill-defined disorder, depression (What is depression?) and was treated with Sulpiride (View Usage). Patient experienced the following unwanted or unexpected effects: haemorrhagic diathesis, oedema peripheral, paraesthesia oral. Sulpiride dosage: . During the same period patient was treated with DEPROMEL 25 (Daily Dose: 150 Milligram(s)) (View Depromel 25 Review and Depromel 25 Label ), LIMAS (View Limas Review and Limas Label ), RESLIN (View Reslin Review and Reslin Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ), MYSLEE (View Myslee Review and Myslee Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), BENZALIN (View Benzalin Review and Benzalin Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ). Patient was hospitalized.